phot

o cr

edit

: H

owar

d Fi

sk |

Vis

itS

eatt

le.o

rg

March 19 – 20, 2015

2015 ANNUAL MEETING

The Conference Center n 800 Pike Street n Seattle, WAPaul B. Griggs, MD n 2015 Annual Meeting Program Chair

CURRENT TRENDS & ADVANCES IN OPHTHALMOLOGY

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Washington State Medical Association and the Washington Academy of Eye Physicians and Surgeons. The WSMA is accredited by the ACCME to provide continuing medical education for physicians.

The WSMA designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 8.75 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission

ACCME ACCREDITATION

Program SESSION 2

10:10 – 10:30 am Toxic Anterior Segment Syndrome (TASS) Nick Mamalis, MD

10:30 – 10:50 am Retinal Manifestations of Systemic Drugs Michael Jumper, MD

10:50 – 11:10 am Corneal Effects of Glaucoma Treatments David Goldman, MD

11:10 – 11:30 am The Surgical Correction of Presbyopia Vance Thompson, MD

11:30 – Noon Panel Discussion

Noon – 2:00 pm Physicians’ lunch and annual business meeting

SESSION 3

2:00 – 2:20 pm Management of Vitreoretinal Complications of Anterior Segment Surgery Michael Jumper, MD

2:20 – 2:40 pm Complications of Femtosecond Laser Cataract Surgery David Goldman, MD

2:40 – 3:00 pm Getting There: Thriving in Modern Day Medicine Vance Thompson, MD

3:00 – 3:20 pm Cataract Surgery in Pseudoexfoliation Nick Mamalis, MD

3:20 – 3:50 pm Coffee break / visit exhibits

SESSION 4

3:50 – 4:05 pm Pearls for IOL Exchange David Goldman, MD

4:05 – 4:20 pm Corneal Collagen Crosslinking: Thera peutic and Refractive Advancements Vance Thompson, MD

4:20 – 4:35 pm Intraoperative Floppy Iris Syndrome (IFIS) Nick Mamalis, MD

4:35 – 4:50 pm AMD Masqueraders Michael Jumper, MD

4:50 – 5:15 pm Panel Discussion

5:15 pm Meeting Adjourns / WAEPS Reception

MARCH 19 | THURSDAY

8:30 am – 4:00 pm WAEPS Coding Seminar Documentation & Reimbursement Seminar (see separate registration)

6:30 – 7:00 pm WAEPS Reception Complimentary – RSVP on registration form

DINNER MEETING

7:00 – 7:45 pm Update on Adjustable IOL Power Technology Nick Mamalis, MD

7:45 – 8:25 pm Lessons Learned from Malpractice Claims Dan Briceland, MD and Paul Weber, JD, OMIC

8:25 – 9:15 pm Incorporating Premium Cataract Surgery: A Physician’s Perspective Vance Thompson, MD

9:15 – 9:30 pm Questions & Answers

MARCH 20 | FRIDAY

7:00 am Registration/Continental Breakfast/ Visit Exhibits

7:55 – 8:00 am Welcome / Introduction Paul B. Griggs, MD – Program Chair

SESSION 1

8:00 – 8:25 am Refractive Surgery My Way Vance Thompson, MD

8:25 – 8:50 am Accommodating IOL Update Nick Mamalis, MD

8:50 – 9:15 am Wet AMD Update Michael Jumper, MD

9:15 – 9:40 am New Diagnostics and Treatments for Ocular Surface Disease David Goldman, MD

9:40 – 10:10 am Coffee break / visit exhibits

Reciprocal ArrangementsWAEPS has reciprocal arrangements with ophthalmology societies in Oregon, Idaho, Montana, Alaska, and British Columbia. Physicians, providing proof of membership in their respective state and province societies, may register at the Active WAEPS Member rate.

DisabilitiesWe encourage participation by all individuals. If you are disabled and require assistance, please notify Debra Alderman at the WAEPS office at 206-956-3650 at least 30 days prior to the course. Advance notification is essential in order for us to serve you better. We’ll be glad to help.

• Name two key details of the US FDA monitored clinical trials of Corneal Collagen Crosslinking

• Describe the biomechanical measuring technology used in Corneal Collagen Crosslinking

• Name two important recent advances in the technology utilized in the surgical correction of presbyopia

• Describe the steps in the process of intraocular lens selection in the surgical correction of presbyopia

• Discuss the implications of refractive surgery for cataract surgeons who are not currently performing corneal refractive surgery

• Describe steps to implementing the comprehensive clinical model to achieve optimal outcomes in the delivery of current refractive surgery

• Describe the mechanisms of action of single lens or hinged, plate-type pseudo-accommodating IOLs, and the inherent advantages of a dual optic accommodating IOL

• Discuss the novel accommodating intraocular lens designs that are being developed and studied at this time

• Describe the key features of adjustable IOLs including lenses that require an invasive adjustment and those that have non-invasive adjustments

• Identify at least two proposed technologies to allow in vivo adjustment of IOL powers

• Name two advantages of light adjustable lens (LAL) technology• Describe steps for dissection of IOLs from capsular bag and the best way

to remove IOLs with an open capsule• Identify the most important elements of vitreous management during

IOL exchange, and two techniques for minimizing endothe lial cell loss during IOL exchange

• Name the medications that are most commonly associated with IFIS and understand their mechanisms of action and their effects on the iris

• Describe the proper preoperative assessment and history in patients with potential IFIS

• Identify at least two preoperative and intraoperative medications and instruments used to prevent complications secondary to IFIS

• Describe the clinical findings in pseudoexfoliation syndrome and three common pathologic findings in the anterior segment of pseudoexfoliation eyes

• Describe the potential intraoperative and late postoperative complications following cataract surgery in pseudoexfoliation patients

• Recognize the clinical findings in patients with TASS

• Discuss the most common causes of TASS including instrument cleaning and sterilization as well as issues with intraocular solutions and medications

• List the steps necessary to investigate an outbreak of TASS as well as to prevent recurrences of TASS

• Differentiate acquired vitelliform lesions and neovascular macular degeneration• Differentiate between age-related macular degeneration, chronic central

serous retinopathy and polypoidal choroidal vasculopathy• Identify two ways that multimodal imaging for wet AMD assessment can be

valuable in practice• Assess the difference between pharmacokinetics and bioavailability of the

different anti-VEGF agents and describe how that may relate to systemic risk• Review the evolving guidelines on injection technique with special attention

to infection prevention• Identify at least two drug categories known to be toxic to the retina including

phenothiazines and quinolones• Name three of the latest screening recommendations for our patients who are

being treated with hydroxychloroquine• Describe ophthalmic manifestations of commonly used drugs including phos-

phodiesterase-5 inhibitors, drugs causing crystalline retinopathy including tamoxifen, drugs that can exacerbate macular edema such as pioglitazone, and newer medications with retinal manifestations including fingolimod

• Discuss preoperative, intraoperative and postoperative considerations for patients undergoing anterior segment surgery with pre-existing diabetic retinopathy, uveitis, or macular degeneration

• Identify intraoperative complications and how they are best managed includ-ing: retained lens fragments, photic maculopathy, and choroidal hemorrhage

• Recognize the causes of femtosecond laser complications, and explain emerging techniques for managing femtosecond laser complications

• Describe new diagnostic tests and two treatment modalities for ocular surface disease

• Name two reasons that treating ocular surface disease can maximize refractive outcomes

• Identify the most common errors that lead to patient harm and result in malpractice claims against ophthalmologists and their practice

• Describe strategies that minimize error, improve patient safety and help prevent malpractice claims

• Identify the factors needed to create and motivate a clinical team to deliver an optimal experience for cataract and refractive patients

• Name two key processes necessary to grow a thriving refractive cataract component in a clinical practice

Objectives Physicians who participate in this program will be able to:

FacultyOMIC PRESENTATIONThursday evening, March 19Lessons Learned From Malpractice Claims

CORNEA/CATARACT:David Goldman, MDGoldman Eye Palm Beach Gardens, FLwww.goldmaneye.com

RETINA:J. Michael Jumper, MDWest Coast Retina Medical Group San Francisco, CAVitreoretinal Fellowship Co-director, California Pacific Medical Center

OPHTHALMIC PATHOLOGY/CATARACT:Nick Mamalis, MDProfessor of OphthalmologyJohn A. Moran Eye CenterUniversity of UtahSalt Lake City, UT

CATARACT AND REFRACTIVE SURGERY:Vance Thompson, MDVance Thompson Vision Sioux Falls, SDAssistant Professor of OphthalmologyUniversity of South Dakota School of Medicine

Daniel J. Briceland, MD OMIC Committee Member

Paul Weber, JDVice-President of Risk Management/Legal at OMIC

Be sure to sign in while in the presentation room to ensure your OMIC discount. Current WAEPS members earn a 10% discount for completion of this activity.www.omic.com

photo credit: ©Tim Thompson

The Washington Academy of Eye Physicians & Surgeons wishes to thank the following exhibitors for their participation in the 2015 Annual Meeting:

Alcon/Novartis

Allergan – Retina

Bausch & Lomb

Beaver Visitec International

Carl Zeiss Meditec

Diopsys

Erickson Laboratories, Inc.

Erickson Labs Northwest

Glaukos

Heidelberg Engineering

Hoya Surgical Optics, Inc.

Imprimis Pharmaceuticals

IRIDEX

Leica Microsystems, Inc.

MARCO

Modernizing Medicine

MST (Microsurgical Technology)

New World Medical, Inc.

Nextech

Nidek, Inc.

Oculus, Inc.

OMIC

Optos, Inc.

Rayner Intraocular Lenses Limited

Sightlife

Sightpath

TearLab

TearScience

ThromboGenics

Vision Matters, LLC

Walman Instrument Group

TransportationThe distance from Sea-Tac Airport to the Olive 8 hotel is approxi-mately 18 miles. Taxi rates vary between $35-$45. The Sound Transit Link Light Rail stops 3 blocks from the Olive 8 hotel, and is $2.50 from the airport.

Many buses stop directly at the Olive 8 hotel. We recommend you visit http://metro.kingcounty.gov/ to find the best route to the hotel.

Cancellation PolicyWAEPS must receive written notification of your cancellation. Submit to the WAEPS office, by email: debra@wsma.org. A $50 processing fee will be deducted. No refunds will be issued after February 13, 2015.

Locationn The Conference Center

800 Pike Street • Seattle, WA 98121206.694.5000

This year’s meeting takes place at the “The Conference Center,” across the street from the main Washington State Convention Center. The Conference Center is located right in the heart of downtown at 8th and Pike Street with easy access to Interstate 5, convenient parking, the airport light rail link and the many great things Seattle has to offer.

99

99

Pike St

Pine St

Pine St

Union St

Pike St

Olive

Way

Olive Way

Boren

Ave

7th Ave

6th Ave

5th Ave

5th Ave

6th Ave

7th Ave

Westlake

Ave4th Ave

4th Ave

3rd Ave2nd Ave

2nd Ave

1st Ave

1st Ave

Western Ave

Alaskan Way Viaduct

Alaskan Way

8th Ave

9th Ave

8th Ave

9th Ave

Stewart St

Stewart St

Virginia

StLenora St

Blanchard

StBell St

Battery

St

5

A T O L I V E 8

TheConference

Center

TheConference

Center

The Washington State Convention Center operates two covered parking garages that adjoin each other and the Convention Center. Unlike most downtown parking garages located in the retail and theater district, Convention Center parking is located in close proximity to two I-5 exits and is accessible from the east side of the freeway.

The Conference Center entrance is on the north side of Pike Street at 8th Avenue. No parking validation is available for WAEPS program participants.

Parking

Lodgingn Hyatt at Olive 8

1635 8th Avenue • Seattle, WA 98101 206.695.1234

A limited block of guest rooms are being held at the Hyatt at Olive 8 hotel, right around the corner from The Conference Center. Rooms are available to attendees at the special rate of $169.00 a night, single or double occupancy (plus tax). To take advantage of this special offer you must reserve your room before February 19 (but we recommend booking early as the block typically sells out). Direct link to our online booking page: https://resweb.passkey.com/go/WAEP15.

A T O L I V E 8

An updated list of exhibitors will be provided at the meeting.

Fee & RegistrationFee for the physician program depends on your WAEPS membership category. Your 2015 dues must be paid in order to register at the member rate. Early-bird discount applies to registrations received no later than February 13, 2015.

This year we encourage all participants to register online on our web-site www.waeps.org/annual-meeting. You’ll have the option to pay online or to request an invoice. If you need assistance or need to register via a hard-copy registration form, please email: waeps@waeps.org or phone: 206-956-3650.